Article Details
Retrieved on: 2018-02-05 05:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Citadel Advisors LLC now owns 93,803 shares of the medical research company's stock worth $3,010,000 after purchasing an additional 68,418 shares during the period. <b>Renaissance Technologies</b> LLC grew its stake in Genomic Health by 10.9% in the 2nd quarter. <b>Renaissance Technologies</b> LLC now ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here